Scientist.com Creates Blockchain Solution That Ensures Marketplace Data Integrity
Scientist.com, the life science industry’s leading online marketplace for outsourced research, announced today that it has launched DataSmartTM , a platform to ensure data and information integrity. DataSmartTM is based on proprietary blockchain technology developed by Scientist.com.
“Blockchain’s ability to ensure the integrity of information is the basis of its use in cryptocurrencies. In biopharma research we need blockchain technology to verify and validate the supply chain and to ensure the integrity of research data,” stated Chris Petersen, CTO and Founder. “Our new DataSmartTM platform enables pharmaceutical and biotech companies to demonstrate that critical supplier information and important research data has not been tampered with and remains unaltered.”
Much of the data created during late-stage preclinical and clinical phases of drug development is submitted electronically to regulators prior to drug approval. Biopharma companies need to prove to regulators that the data has not been tampered with since it was first obtained. Within the biopharma industry, late-stage preclinical and clinical research is subject to the strict guidelines of 21CFR Part 11, under which electronic records are considered trustworthy and equivalent to paper records.
“The cost and time spent adhering to 21CFR Part 11 has made it prohibitive to ensure data integrity at earlier stages of the drug discovery and development process,” commented Kevin Lustig, CEO and Founder. “Our new DataSmartTM platform makes it possible to extend data integrity protections throughout the entire drug research process, from concept to clinic and beyond.”
Scientist.com is the world's leading marketplace for outsourced research. The marketplace simplifies the entire research sourcing process, saving time and money and providing access to the latest innovative tools and technologies while maintaining full compliance with an organization’s procurement policies. Scientist.com operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, VWR and the US National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised more than $33 million from Leerink Transformation Partners, 5AM Ventures, Heritage Provider Network, Bootstrap Ventures and Hollywood producer Jack Giarraputo among others. Visit scientist.com to learn more.
Director of Communications
+1 858-455-1300 ext. 401
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
NY-ZODIAC11.12.2018 15:03 | Pressemeddelelse
Zodiac Appoints Derek Harrar CEO
O-RAN-ALLIANCE11.12.2018 15:03 | Pressemeddelelse
The O-RAN Alliance Announces New Board Members
SEOUL-SEMICONDUCTOR11.12.2018 15:03 | Pressemeddelelse
Seoul Semiconductor Wins Patent Litigation against Everlight in Germany and Is Awarded Statutory Litigation Costs
PA-BRIGHTLINE/NETEASE11.12.2018 14:02 | Pressemeddelelse
The Brightline Initiative Announces Strategic Partnership with NetEase
QUOTIENT-SCIENCES11.12.2018 14:02 | Pressemeddelelse
Quotient Sciences Conducts Integrated Translational Pharmaceutics® Program in U.S. with Druggability Technologies
AMRA-MEDICAL11.12.2018 12:30 | Pressemeddelelse
AMRA Receives U.S. FDA Clearance for AMRA® Profiler, a Magnetic Resonance Diagnostic Software Application Enabling Non-Invasive Evaluation of Body Composition
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum